Comparison on Surgical Outcomes of Mini-Versus Standard-Percutaneous Nephrolithotomy in Staghorn Calculi: A Systematic Review and Meta-Analysis

微创经皮肾镜取石术与标准经皮肾镜取石术治疗鹿角状结石的手术疗效比较:系统评价和荟萃分析

阅读:1

Abstract

Percutaneous Nephrolithotomy (PCNL) has become the standard for managing staghorn calculi. Smaller access sheath Mini-PCNL (M-PCNL) has been known for its advantages in surgical outcomes compared with Standard-PCNL (S-PCNL) in various settings. We conducted this systematic review to compare surgical outcomes and postoperative complications of M-PCNL vs. S-PCNL in staghorn calculi treatment. A systematic search of the literature was performed on PubMed, Cochrane Library, ProQuest, Scopus, ClinicalTrials.gov, and Google Scholar according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA Statement). Five randomized controlled trial (RCT) and 5 cohort studies were included. Risk of bias assessment was evaluated using Cochrane risk of bias (RoB) 2 and Cochrane RoB in Nonrandomized Studies - of Interventions (ROBINS-I). Ten studies involving 1733 staghorn calculi patients met the inclusion criteria. The stone-free rate (SFR) was comparable (odds ratio (OR) 1.13, 95% CI: 0.90-1.43, P = .28) compared to S-PCNL. Pooled analysis showed that M-PCNL resulted in a significantly lower shorter operative time (mean differences (MD) 14.06, 95% CI: 6.09-22.03, P < .001), lower blood transfusion (OR 0.46, 95% CI: 0.29-0.72, P < .001), and lower hemoglobin drop (MD !0.37, 95% CI: !0.72 to !0.03, P = .03) compared to S-PCNL. This meta-analysis suggests that while M-PCNL has comparable SFR to S-PCNL, it offers benefits in terms of shorter operative time, reduced blood transfusion needs, and less hemoglobin drop.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。